Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DMRA | URGN | SRPT | ||
| Company | Damora Therapeutics Inc | Urogen Pharma Ltd | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.99 | 39.08 | 18.05 | ||
| High | 31.76 | 40.87 | 18.13 | ||
| Low | 29.89 | 38.30 | 17.02 | ||
| Latest | 30.95 | 39.80 | 17.61 | ||
| Change | -0.04 | +0.61 | -0.35 | ||
| % Change | -0.13% | +1.56% | -1.95% | ||
| Volume | 622,500 | 907,800 | 3,508,800 | ||
| 20-Day Average Volume | 985,275 | 753,080 | 4,086,150 | ||
| Previous Close | 30.99 | 39.19 | 17.96 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.19 | 36.61 | 18.01 | ||
| 20-Day Raw Stochastic | 93.36% | 90.03% | 40.44% | ||
| 20-Day Relative Strength | 61.41 | 70.39 | 47.90 | ||
| Weighted Alpha | -6.12 | +157.88 | +7.35 | ||
| Today's Opinion | 72% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 72% Buy | 100% Buy | 40% Sell | ||
| Last Month's Opinion | 40% Sell | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.42% since 07/08/26 | +4.65% since 07/08/26 | -12.86% since 07/08/26 | ||
| Low | 26.29 on 07/13/26 | 36.81 on 07/13/26 | 17.02 on 07/15/26 | ||
| High | 31.76 on 07/15/26 | 40.87 on 07/15/26 | 20.88 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +54.21% since 06/15/26 | +28.95% since 06/15/26 | +11.67% since 06/15/26 | ||
| Low | 19.49 on 06/16/26 | 30.14 on 06/16/26 | 15.39 on 06/16/26 | ||
| High | 31.76 on 07/15/26 | 40.87 on 07/15/26 | 20.88 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +16.31% since 04/15/26 | +85.03% since 04/15/26 | -18.96% since 04/15/26 | ||
| Low | 18.59 on 06/10/26 | 21.25 on 04/16/26 | 14.68 on 06/11/26 | ||
| High | 31.76 on 07/15/26 | 40.87 on 07/15/26 | 23.49 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | +29.23% since 01/15/26 | +103.68% since 01/15/26 | -17.36% since 01/15/26 | ||
| Low | 16.50 on 03/20/26 | 16.50 on 03/30/26 | 14.68 on 06/11/26 | ||
| High | 33.99 on 02/24/26 | 40.87 on 07/15/26 | 24.68 on 01/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,907,528 | 1,909,415 | 1,896,145 | ||
| Shares Outstanding, K | 61,553 | 48,722 | 105,576 | ||
| Annual Sales | 0 | 109,790,000 | 2,198,240,000 | ||
| Annual Net Income | -209,840,000 | -153,490,000 | -713,410,000 | ||
| Last Quarter Sales | 0 | 50,960,000 | 730,800,000 | ||
| Last Quarter Net Income | -27,780,000 | -23,570,000 | 330,960,000 | ||
| 60-Month Beta | 1.46 | 1.56 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 05/12/26 | -0.47 on 05/06/26 | 3.16 on 05/06/26 | ||
| Earnings Date | 08/04/26 | 08/06/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 29.41 | ||